Deltex Medical Group PLC NHS hospital invests in ODM equipment
November 04 2016 - 3:00AM
RNS Non-Regulatory
TIDMDEMG
Deltex Medical Group PLC
04 November 2016
4 November 2016
Deltex Medical Group plc
("Deltex Medical", "Deltex" or "the Company")
NHS hospital invests in ODM equipment
Deltex Medical Group plc (AIM: DEMG), the global leader in
Oesophageal Doppler Monitoring ("ODM"), is pleased to announce its
most substantial account win in a UK NHS hospital for more than two
years.
A 450 bed NHS hospital in the South-East of England has acquired
six CardioQ-ODM+ monitors and an initial stock of single patient
oesophageal probes for use in its peri-operative surgical care. The
hospital invested in ODM in response to clinician demand to replace
the alternative technology purchased by the Trust as a result of
the 2013 NHS national implementation programme for Intra-Operative
Fluid Management. The initial order was worth over GBP30,000 and
although this does not alter full year forecasts, it does reflect a
generally improving UK performance in the second half of the year
to date.
Ewan Phillips, Deltex Medical's Chief Executive, commented:
"We are encouraged both that groups of clinicians are insisting
on using ODM rather than alternative technologies and that NHS
hospitals will support these clinicians financially to deliver
better outcomes and reduce costs. This order is further evidence of
improving trends in our UK business following the launch of the
TruFlow probes in May, the presentation of excellent results from
the largest ever randomised controlled trial of ODM in June and the
further presentation in July of a trial from a major NHS hospital
confirming better comparative outcomes from using ODM during
surgery."
For further information, please contact:-
Deltex Medical Group 01243 774 837
plc investorinfo@deltexmedical.com
Nigel Keen, Chairman
Ewan Phillips, Chief
Executive
Jonathan Shaw, Group
Finance Director
Barry Curtis, Company
Secretary
Nominated Adviser &
Broker
Arden Partners plc 020 7614 5900
Chris Hardie
Financial Public Relations
IFC Advisory 020 3053 8671
Tim Metcalfe
Graham Herring
Heather Armstrong
Notes for Editors
Deltex Medical manufactures and markets haemodynamic monitoring
technologies. Deltex Medical's ODM is the only technology to
measure continuously blood flow in the central circulation in real
time. Minimally invasive, easy to set up and quick to focus, the
technology generates a low-frequency ultrasound signal, which is
highly sensitive to changes in flow and measures them immediately.
Deltex has been the only company in the enhanced haemodynamic space
to build a robust and credible evidence base proving the clinical
and economic benefits of its core technology, ODM. Randomised,
controlled trials using Doppler have demonstrated that early fluid
management intervention will reduce post-operative complications,
reduce intensive care admissions, and reduce the length of hospital
stay.
Company goal
ODM is increasingly recognised as a standard of care for
patients undergoing major surgery and in critical care. The broader
clinical area of haemodynamic management of which ODM is a core
constituent is also now becoming widely accepted as an important
major new medical modality. Consequently, the Company's focus is on
maximising value from the opportunities presented as enhanced
haemodynamic management is adopted into routine clinical practice
around the world.
The Company is currently in the implementation phase of
achieving this goal in a number of territories worldwide, operating
directly in the UK, USA, Spain and Canada and through distribution
arrangements in a further 30 countries.
There are over 3,200 monitors installed in hospitals around the
world and around 700,000 patients have been treated to date using
Deltex Medical's single patient disposable probes.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAVXLFBQFFZFBB
(END) Dow Jones Newswires
November 04, 2016 03:00 ET (07:00 GMT)
Deltex Medical (LSE:DEMG)
Historical Stock Chart
From Apr 2024 to May 2024
Deltex Medical (LSE:DEMG)
Historical Stock Chart
From May 2023 to May 2024